Wesbanco Bank Inc Gilead Sciences, Inc. Transaction History

Wesbanco Bank Inc

  • $2.64 Billion
  • Q2 2024

A detailed history of Wesbanco Bank Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wesbanco Bank Inc holds 20,162 shares of GILD stock, worth $1.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
20,162
Previous 20,567 1.97%
Holding current value
$1.7 Million
Previous $1.51 Million 8.17%
% of portfolio
0.05%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024
SELL
$63.15 - $72.88 $25,575 - $29,516
-405 Reduced 1.97%
20,162 $1.38 Million
Q1 2024

Apr 23, 2024
BUY
$71.58 - $87.29 $567,414 - $691,947
7,927 Added 62.71%
20,567 $1.51 Million
Q4 2023

Feb 16, 2024
SELL
$73.27 - $83.09 $612,024 - $694,050
-8,353 Reduced 39.79%
12,640 $1.02 Million
Q3 2023

Dec 11, 2023
SELL
$73.94 - $80.67 $37,487 - $40,899
-507 Reduced 2.36%
20,993 $1.57 Million
Q2 2023

Jul 13, 2023
SELL
$76.01 - $86.7 $41,729 - $47,598
-549 Reduced 2.49%
21,500 $1.66 Million
Q1 2023

Apr 21, 2023
SELL
$77.31 - $88.08 $64,708 - $73,722
-837 Reduced 3.66%
22,049 $1.83 Million
Q4 2022

Jan 18, 2023
BUY
$62.32 - $89.47 $485,223 - $696,613
7,786 Added 51.56%
22,886 $1.97 Million
Q3 2022

Oct 13, 2022
SELL
$59.54 - $68.01 $1.04 Million - $1.19 Million
-17,547 Reduced 53.75%
15,100 $932,000
Q2 2022

Jul 18, 2022
SELL
$57.72 - $65.01 $108,225 - $121,893
-1,875 Reduced 5.43%
32,647 $2.02 Million
Q1 2022

Apr 25, 2022
SELL
$57.92 - $72.58 $897,412 - $1.12 Million
-15,494 Reduced 30.98%
34,522 $2.05 Million
Q4 2021

Feb 02, 2022
SELL
$64.88 - $73.64 $70,329 - $79,825
-1,084 Reduced 2.12%
50,016 $3.63 Million
Q3 2021

Oct 12, 2021
SELL
$67.69 - $73.03 $4.78 Million - $5.16 Million
-70,594 Reduced 58.01%
51,100 $3.57 Million
Q2 2021

Aug 09, 2021
SELL
$63.47 - $69.35 $11,678 - $12,760
-184 Reduced 0.15%
121,694 $8.38 Million
Q1 2021

May 06, 2021
BUY
$60.0 - $68.46 $990,000 - $1.13 Million
16,500 Added 15.66%
121,878 $7.88 Million
Q3 2020

Nov 13, 2020
BUY
$62.1 - $78.08 $3.84 Million - $4.83 Million
61,861 Added 142.15%
105,378 $6.66 Million
Q2 2020

Jul 14, 2020
SELL
$72.34 - $84.0 $197,415 - $229,236
-2,729 Reduced 5.9%
43,517 $3.35 Million
Q1 2020

May 12, 2020
BUY
$62.63 - $80.22 $881,893 - $1.13 Million
14,081 Added 43.78%
46,246 $3.46 Million
Q4 2019

Feb 13, 2020
SELL
$61.62 - $67.78 $358,690 - $394,547
-5,821 Reduced 15.32%
32,165 $2.09 Million
Q3 2019

Nov 07, 2019
BUY
$62.51 - $69.0 $624,912 - $689,793
9,997 Added 35.72%
37,986 $2.41 Million
Q2 2019

Aug 13, 2019
SELL
$61.87 - $69.38 $61,993 - $69,518
-1,002 Reduced 3.46%
27,989 $1.89 Million
Q1 2019

May 09, 2019
BUY
$62.53 - $70.05 $58,090 - $65,076
929 Added 3.31%
28,991 $1.88 Million
Q4 2018

Feb 05, 2019
BUY
$60.54 - $79.0 $271,219 - $353,920
4,480 Added 19.0%
28,062 $1.76 Million
Q3 2018

Nov 09, 2018
SELL
$71.28 - $78.92 $70,210 - $77,736
-985 Reduced 4.01%
23,582 $1.82 Million
Q2 2018

Aug 08, 2018
SELL
$64.88 - $75.68 $837,406 - $976,801
-12,907 Reduced 34.44%
24,567 $1.74 Million
Q1 2018

May 18, 2018
BUY
$72.84 - $88.8 $818,575 - $997,934
11,238 Added 42.83%
37,474 $2.83 Million
Q4 2017

Feb 01, 2018
SELL
$71.15 - $83.52 $124,583 - $146,243
-1,751 Reduced 6.26%
26,236 $1.88 Million
Q3 2017

Nov 02, 2017
SELL
$72.11 - $85.47 $48,097 - $57,008
-667 Reduced 2.33%
27,987 $2.27 Million
Q2 2017

Aug 08, 2017
BUY
N/A
28,654
28,654 $2.03 Million

Others Institutions Holding GILD

# of Institutions
1,880
Shares Held
1.02B
Call Options Held
12M
Put Options Held
8.96M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $105B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Wesbanco Bank Inc Portfolio

Follow Wesbanco Bank Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wesbanco Bank Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email